Your Beacon Purchase Makes a Difference!

In the spirit of bringing light – and happiness! – to gardens everywhere, PanAmerican Seed donates a percentage of its global Beacon Impatiens sales to a less-widely known charitable organization each year.

For the 2022 garden season, PanAmerican Seed is partnering with two foundations fighting against low vision issues, such as macular degeneration – a disease affecting the eyesight of millions of people worldwide. This affliction was brought to our attention through the experience of one of our own team members. Spectrios Institute for Low Vision (Illinois, USA) and the Macular Society (United Kingdom) provide family support, fund raising, and education empowerment for their members. They also invest in research to offer the hope of new and improved treatments for those living with low vision issues.

Macular Society logo
Spectrios Institute logo
“As we enter the third year of our charitable giving through sales of Beacon Impatiens, we are gratified to see the impact gardeners are making through their purchases on the lives of so many fellow humans across the world.”

– Sean Valk, Global Sales Director for PanAmerican Seed

Low vision is the loss of eyesight and vision capabilities that cannot be corrected through lenses or general surgery. While not blindness, as limited sight remains, low vision can include blind spots, poor night vision and blurriness. Many causes include age-related macular degeneration, glaucoma and diabetes, yet low vision can affect people of all ages.

Spectrios Institute for Low Vision supports approximately 3,000 people in their State of Illinois. The team empowers children and adults with vision loss to optimize their visual capabilities and independence through the use of prescriptive tools, technology and rehabilitative training. Donations help with providing low vision exams, accessibility tools, technology training, support groups, as well as training the low vision providers of the future.


The Macular Society, located in the UK, is on a mission to beat Macular Disease. It affects 1.5 million people in the UK – nearly twice as many than those affected by dementia. Through funding world-class research and providing the best advice and support to patients, the Macular Society will beat the fear and isolation of macular disease. Their efforts will also ensure eye health is pushed to the top of the national agenda.